Literature DB >> 9573549

Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure.

P Stenvinkel1, O Heimbürger, C H Tuck, L Berglund.   

Abstract

Atherosclerotic cardiovascular disease and malnutrition are widely recognized as leading causes of the increased morbidity and mortality observed in uremic patients. Levels of lipoprotein (a) [Lp(a)], an established cardiovascular risk factor, are elevated in uremic patients. Moreover, low serum albumin levels indicating malnutrition have been associated with elevated plasma Lp(a) levels in dialysis patients. However, serum albumin levels are also influenced by an inflammatory reaction. The present study was undertaken to further investigate the relationship between Lp(a), inflammation and malnutrition in patients with chronic renal failure (CRF) prior to the initiation of renal replacement therapy, and to investigate the potential relation between these factors and apo(a)-isoform size, an important determinant of plasma Lp(a) levels. A total of 83 patients (mean age 52 +/- 1 year) with terminal (creatinine clearance 9 +/- 1 ml/min) CRF were cross sectionally investigated. In addition to lipid parameters and apo(a)-isoform size, C-reactive protein (CRP), nutritional parameters including serum levels of albumin and body composition (dual energy x-ray absorptiometry), as well as a subjective global assessment (SGA) and the prevalence of cardiovascular disease (CVD) were evaluated. Malnourished patients (N = 39) had a significantly (P < 0.05) higher median plasma Lp(a) level (19.5 mg/dl) as compared to 44 well-nourished patients, (11.7 mg/dl). No difference was found for other lipid or lipoprotein parameters. A significant relationship was found between CRP and plasma Lp(a), whereas no significant relation was observed between plasma Lp(a) and serum albumin levels. The apo(a)-isoform distribution was similar among malnourished and well-nourished patients. There was no difference in nutritional parameters when comparing patients with small- and large-size apo(a) isoforms. However, a subgroup of patients (12%) with no detectable apo(a)-bands and low Lp(a) levels had significantly higher lean body mass. The present study demonstrates elevated plasma Lp(a) levels in CRF patients with signs of malnutrition, even though no direct relationships between plasma Lp(a) levels and various nutritional parameters were observed. The observed relationship between Lp(a) and CRP suggests that inflammatory factors, more prevalent in patients with malnutrition, may contribute to the Lp(a) increase in malnourished CRF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573549     DOI: 10.1046/j.1523-1755.1998.00880.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Causes and consequences of lipoprotein(a) abnormalities in kidney disease.

Authors:  Florian Kronenberg
Journal:  Clin Exp Nephrol       Date:  2013-10-16       Impact factor: 2.801

2.  The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

Authors:  J Lin; F B Hu; E B Rimm; N Rifai; G C Curhan
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

3.  Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.

Authors:  Xiang Gao; Lianghu Huang; Fabrizio Grosjean; Vittoria Esposito; Jianxiang Wu; Lili Fu; Huimin Hu; Jiangming Tan; Cijian He; Susan Gray; Mukesh K Jain; Feng Zheng; Changlin Mei
Journal:  Kidney Int       Date:  2011-01-19       Impact factor: 10.612

4.  Lipoprotein(a): biology and clinical importance.

Authors:  Sally P A McCormick
Journal:  Clin Biochem Rev       Date:  2004-02

5.  Dyslipidemia associated with chronic kidney disease.

Authors:  Vasilis Tsimihodimos; Zoi Mitrogianni; Moses Elisaf
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

6.  Salivary levels of interleukin-6 and tumor necrosis factor-α in patients undergoing hemodialysis.

Authors:  Faezeh Khozeymeh; Mojgan Mortazavi; Navid Khalighinejad; Mehrdad Akhavankhaleghi; Milad Alikhani
Journal:  Dent Res J (Isfahan)       Date:  2016 Jan-Feb

7.  Serum lipoprotein (a) associates with a higher risk of reduced renal function: a prospective investigation.

Authors:  Liping Xuan; Tiange Wang; Huajie Dai; Bin Wang; Jiali Xiang; Shuangyuan Wang; Hong Lin; Mian Li; Zhiyun Zhao; Jieli Lu; Yuhong Chen; Yu Xu; Weiqing Wang; Min Xu; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2020-07-23       Impact factor: 5.922

Review 8.  Non-genetic influences on lipoprotein(a) concentrations.

Authors:  Byambaa Enkhmaa; Lars Berglund
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.